{"slug": "why-america-s-ai-boom-isn-t-an-industrial-boom", "title": "Why America's AI Boom Isn't an Industrial Boom", "summary": "McKinsey Global Institute reports that despite hyperscalers' AI investment surging 50-fold over two decades to $750 billion in 2025, productive investment as a share of U.S. GDP has barely budged, indicating the AI boom has not yet translated into a broader industrial boom. The U.S. faces higher manufacturing costs—40% higher for semiconductors and 60% for pharmaceuticals than competitive locations—and factory structure investment fell 6% in 2025 after peaking in 2024, while China adds $4.4 trillion in net productive assets annually, four times the U.S. amount.", "body_md": "America’s AI investment boom is real. However, this surge has yet to result in the kind of industrial revolution that many had hoped for.\n\nTo be sure, the United States is experiencing a genuine boom in AI investment. The hyperscalers accelerated their R&D and capital investment [50-fold](https://www.mckinsey.com/mgi/our-research/The-race-takes-off-in-the-next-big-arenas-of-competition) over the past [two decades](https://www.mckinsey.com/mgi/our-research/The-race-takes-off-in-the-next-big-arenas-of-competition) to [$750 billion in 2025](https://www.mckinsey.com/mgi/our-research/The-race-takes-off-in-the-next-big-arenas-of-competition) compared to [$15 billion in 2005](https://www.mckinsey.com/mgi/our-research/The-race-takes-off-in-the-next-big-arenas-of-competition). By the end of 2026, total investment by these hyperscalers could approach [$1 trillion](https://www.mckinsey.com/mgi/our-research/The-race-takes-off-in-the-next-big-arenas-of-competition).\n\nBut here’s the catch: despite that record level of spending, [productive investment](https://apps.bea.gov/iTable/?ReqID=10&step=2) as a share of U.S. GDP has barely budged. That measure matters because it tracks spending on the economy’s productive assets—the factories, equipment, infrastructure, and intellectual property that underpin future productivity and competitiveness. The AI boom is real, but it has yet to reshape investment across the broader industrial economy.\n\nThis disconnect matters because productive investment is a leading indicator of competitiveness and of where production, jobs, and growth will occur. While the United States has outperformed most advanced economies on investment since the global financial crisis, China is adding roughly [$4.4 trillion](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) in net productive assets annually, roughly [four times](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) the equivalent amount in the United States.\n\nWe estimate that addressing the most critical U.S. import dependencies could require on the order of $2 trillion in additional manufacturing investment or about [6% of GDP](https://www.mckinsey.com/mgi/our-research/ramping-up-manufacturing-in-america). At the end of [2025](https://apps.bea.gov/iTable/?ReqID=10&step=2), investment in factory structures fell [6%](https://apps.bea.gov/iTable/?ReqID=10&step=2) after peaking in [2024](https://apps.bea.gov/iTable/?ReqID=10&step=2). Meanwhile, investment in general industrial equipment was essentially [flat](https://apps.bea.gov/iTable/?ReqID=10&step=2), although there was a slight uptick in machinery and equipment investment in the [first quarter](https://amtonline.org/article/machinery-orders-continue-rally-in-q1-2026-despite-uncertainty-from-iran-war) of this year. The reshoring momentum that started in [2022](https://www.federalreserve.gov/econres/notes/feds-notes/from-plans-to-starts-examining-recent-trends-in-manufacturing-plant-construction-20250114.html) has plateaued in the numbers, and any recent announcements will take time to translate into construction and development.\n\nOne clear challenge to sparking a U.S. industrial renaissance: it’s expensive to make in America. Across most steps of the production process—construction, labor, materials, equipment, and time to market—the United States is a costly place to invest. Excluding any subsidies, the all-in costs to build products like semiconductors and pharmaceuticals are roughly [40%](https://www.semiconductor-digest.com/building-fabs-in-the-u-s-vs-taiwan-twice-as-long-twice-as-much/) and [60%](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) higher, respectively, than in the most competitive locations, while the cost of developing a new antibody medicine is [2.7 times](https://www.mckinsey.com.br/en/our-insights/biopharma-r-and-d-the-evolving-formula-for-discovery-and-development) as expensive compared to China. [Two factors](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) constitute the bulk of the cost gap. The first is more costly and slower capex delivery. U.S. construction costs are about [double](https://www.semiconductor-digest.com/building-fabs-in-the-u-s-vs-taiwan-twice-as-long-twice-as-much/) what they are in Asia, and construction times can be [twice as long](https://www.semiconductor-digest.com/building-fabs-in-the-u-s-vs-taiwan-twice-as-long-twice-as-much/): recent nuclear projects have taken up to a [decade](https://pris.iaea.org/PRIS/CountryStatistics/ReactorDetails.aspx?current=937&lang=en) to complete compared to [six years](https://world-nuclear.org/nuclear-reactor-database/details/fuqing-5) in China. Second, labor costs are [two to five times](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) more than in China or Taiwan, a difference that used to be offset by productivity differences. But in like-for-like industrial settings, productivity differences have all but vanished. In advanced fabs, for instance, Taiwanese engineers produce about a [quarter more](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) per worker than in the United States, where wages are more than 2.7 times as high.\n\nTo close such gaps, companies hoping to build at home could start by using modular, off-site methods that can cut project timelines by [half](https://www.mckinsey.com/industries/private-capital/our-insights/scaling-bigger-faster-cheaper-data-centers-with-smarter-designs) and capital costs by [10 to 20%](https://www.mckinsey.com/industries/private-capital/our-insights/scaling-bigger-faster-cheaper-data-centers-with-smarter-designs), and deploying technology, collaborative contracting, and more to lower construction costs. Also AI- and robot-first operating models can help employers transform labor productivity. Our analysis found such steps could close [half to two-thirds](https://www.mckinsey.com/mgi/our-research/catalyzing-competitiveness-where-investment-happens-and-why) of the U.S. cost gap.\n\nWhere cost competitiveness isn’t possible, companies can compete on service quality, brand, customer proximity, and innovation. Complex drug therapies, for example, command premium margins and a [decade or more](https://www.fda.gov/drugs/development-approval-process-drugs/frequently-asked-questions-patents-and-exclusivity) of effective commercial exclusivity. Performance and trust can sustain premium prices. Increasingly, unrestricted access to the U.S. market also matters.\n\nPolicymakers face their own challenges. They cannot protect, nurture, ringfence, or subsidize every industry. Instead, they can support industries that can solve America’s so-called “[Achilles heels](https://www.mckinsey.com/mgi/our-research/ramping-up-manufacturing-in-america),” the roughly [25%](https://www.mckinsey.com/mgi/our-research/ramping-up-manufacturing-in-america) of imported manufactured goods that are critical to national security, exposed to supply concentration, and derived from geopolitically distant trading partners. The scale of intervention required, whether selective trade measures, financial support, industrial policy, or other measures, is substantial. The task is about triage, deciding which industries justify a scale of intervention that would change the playing field, starting with the [25%](https://www.mckinsey.com/mgi/our-research/ramping-up-manufacturing-in-america) of imported manufactured goods in which dependencies are most pronounced. Policymakers will also want to work to address existing skews in the international trading system.\n\nThe U.S. technology boom shows the country can mobilize capital at breathtaking speed. Kicking off an industrial renaissance raises a harder question: Is the United States willing to change how it builds industry and absorb higher costs when doing so isn’t enough?", "url": "https://wpnews.pro/news/why-america-s-ai-boom-isn-t-an-industrial-boom", "canonical_source": "https://time.com/article/2026/09/02/why-america-s-ai-boom-isn-t-an-industrial-boom/", "published_at": "2026-09-02 19:46:10+00:00", "updated_at": "2026-09-02 20:23:46.550267+00:00", "lang": "en", "topics": ["artificial-intelligence", "ai-policy"], "entities": ["McKinsey Global Institute", "United States", "China"], "alternates": {"html": "https://wpnews.pro/news/why-america-s-ai-boom-isn-t-an-industrial-boom", "markdown": "https://wpnews.pro/news/why-america-s-ai-boom-isn-t-an-industrial-boom.md", "text": "https://wpnews.pro/news/why-america-s-ai-boom-isn-t-an-industrial-boom.txt", "jsonld": "https://wpnews.pro/news/why-america-s-ai-boom-isn-t-an-industrial-boom.jsonld"}}